查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球高級傷口護理市場
市場調查報告書
商品編碼
1143387

2022-2029 年全球高級傷口護理市場

Global Advanced Wound Care Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

高級傷口護理市場規模預計將在 2021 年達到 103.189 億美元，在預測期間（2022-2029 年）以 4.90% 的複合年增長率增長。

Advanced Wound Care 包括治療急性和慢性傷口的產品，例如潰瘍、燒傷和手術後傷口。薄膜和泡沫敷料、水凝膠、藻酸鹽和水膠體等產品可保持傷口水合以促進癒合而不阻塞傷口。該市場通過提供易於獲得且價格合理的產品來為患有慢性傷口的患者提供解決方案，以方便他們使用。先進的傷口護理管理市場報告還涵蓋了各種競爭技術，如先進的傷口敷料技術、有害壓力傷口護理 (NPWT)、生物製劑/生物活性產品和高壓氧治療設備。

市場動態

推動市場增長的主要因素包括老齡化社會、技術進步、糖尿病患者增加、患者意識提高以及患者醫療費用增加。

增加與傷口護理相關的研究和投資活動預計將推動市場增長

正在進行的研究活動的存在預計將推動傷口護理市場。例如，2018 年 12 月，麥吉爾大學健康中心 (MUHC) 和麥吉爾大學的一項新研究發現，使用名為 Swift Skin and Wound 的新應用程序可以準確測量皮膚瑕疵並繪製其進展情況，可用於臨床實踐。它被證明具有顯著影響管理和患者結果的潛力。該應用程序目前正在蒙特利爾麥吉爾大學健康中心 (MUHC) 的臨床醫生和醫療保健專業人員使用。

此外，根據俄亥俄州立大學研究人員團隊最近在 2019 年 3 月在線發表在《科學報告》上的一項研究，電整流繃帶可以殺死傷口周圍的細菌，幫助傷口更快癒合。說。 ipLine Medical, Inc（加利福尼亞州坎貝爾）籌集了 1200 萬美元的 E 輪融資，以支持 Zip 手術皮膚閉合產品的全球商業化和先進工具的開發，以降低捆綁式護理環境中的成本。這筆資金得到了新投資者 HighCape Partners（紐約州紐約市）和現有投資者 MVM Life Science Partners LLP（馬薩諸塞州波士頓）的支持。該公司在開發具有成本效益的非侵入性手術皮膚閉合器方面具有創新地位，可提高手術效率和患者滿意度。該公司的旗艦產品是一種外科皮膚閉合裝置，已被美國食品和藥物管理局 (FDA) 列為 I 類 510(k) 豁免。

與傷口護理產品相關的高成本是阻礙市場增長的關鍵因素之一

根據英國國民健康服務 (NHS) 的數據，靜脈性腿部潰瘍 (VLU)、壓力性潰瘍 (PU) 和 DFU 是英國最昂貴的傷口之一。英國的一項研究估計，這些傷口護理的成本超過 45 億英鎊（57.2 億美元），這還不包括合併症的護理和患者自身的成本。除了抗微生物敷料（銀、碘、蜂蜜）之外，沒有比非藥物敷料更適合用於慢性傷口癒合的堅固且具有成本效益的敷料。

此外，傷口護理產品的處方量很大，並根據需要使用，這增加了成本。與傳統的傷口敷料相比，高級傷口護理產品價格昂貴。因此，儘管癒合緩慢，許多患者仍選擇傳統敷料。這對高級傷口敷料領域的發展構成了重大挑戰。在美國，治療慢性傷口的費用非常高，每次治療費用從 2,000 美元到 10,000 美元不等，具體取決於症狀和護士費用。在美國，管理壓瘡的費用估計為 7,000 至 55,000 美元，所有治療的年費用估計為數十億日元。

COVID-19 影響分析

COVID-19 的爆發將在預測期的早期影響高級傷口護理市場。由於全國范圍內的停工、傷口護理服務被拒絕、擇期手術的取消或推遲等，預計高級傷口護理市場在預測期內將出現一定的下降。由於病毒的傳播，高級傷口護理市場的許多公司被迫暫停生產和生產運營。此外，新的政府法規正在暫停業務，這對高級傷口護理市場的盈利動態產生了直接影響。醫院門診部 (HOPD) 傷口診所一直是治療這些傷口的主要護理場所，但在最初的 COVID 激增期間關閉了其中一些設施，許多慢性傷口患者無法看醫生，延誤治療，並搬到醫生辦公室接受治療。英國已經取消了超過 200 萬次非緊急程序，以騰出醫療資源來抗擊這一流行病。同樣，在宣布冠狀病毒大流行後，美國醫院的就診人數下降了 30-60%。事實上，有一些證據表明，自大流行開始以來，傷口嚴重程度有所增加，更複雜產品的使用有所增加，不幸的是，截肢人數有所增加。

行業分析

全球高級傷口護理市場基於波特五力、監管分析、報銷分析、供應鏈分析、定價分析和技術進步等各種行業因素對市場進行了深入分析。 .

細分分析

預計滲出液管理部門將在全球先進傷口護理市場中佔據最大的市場份額

滲出液是從傷口滲出的液體，在癒合過程中起著重要作用。滲出物主要是水，但也包含營養物質、蛋白質、廢物和各種細胞類型，如血小板和巨噬細胞。滲出液管理對於避免患者因傷口引起的明顯疼痛、不適和痛苦、為傷口癒合創造最佳環境以及防止感染風險至關重要。

但是，在慢性傷口中，滲出液會對傷口癒合產生不利影響。滲出液，尤其是來自慢性傷口的滲出液，含有多種元素（細胞碎片和□），它們對傷口床和傷口周圍完整的皮膚都具有高度腐蝕性。滲出液管理是護理慢性傷口患者的醫療保健專業人員面臨的最大挑戰之一。濕傷口管理在敷料材料和護理時間方面成本高昂，但在當前的醫療經濟環境下，我們更注重降低成本。

區域分析

北美在全球醫療保健 IT 市場中佔有最大的市場份額。

由於產品創新、糖尿病患者發病率上升、醫療保健支出上升以及該地區人口老齡化的增長，北美在 2019 年主導全球高級傷口護理市場，預計在 ( 2020-2027）。預計該地區傷口病例的增加將提振市場。例如，美國國立衛生研究院估計，65 歲以上的人口中有 3% 最終會出現傷口。由於創傷和潰瘍在資源貧乏國家和其他地方的地方性，預計發病率會更高。因此，越來越多的傷口正在推動市場。

預計該地區主要參與者對傷口管理的持續研究活動將提振市場。 Cedars-Sinai Health System 等人的 Brennan Spiegel 於 2019 年 8 月 14 日在開放獲取期刊 PLOS ONE 上發表的一項研究發現，治療性虛擬現實 (VR) 可以減輕傷口護理和焦慮症期間的疼痛。已被證明正在成為一種積極的非藥物治療方式，用於分散患者的注意力。因此，正在進行的研究活動的存在推動了市場。在該地區，開發傷口護理產品的主要參與者的存在預計將推動市場發展。例如，2019 年 3 月 4 日，Organogenesis Holdings Inc. 宣布其 PuraPly Antimicrobial (PuraPly AM) 產品對一系列先前對治療無反應的複雜慢性傷口的癒合過程產生了積極影響。因此，市場受到主要參與者推出各種傷口護理產品的推動。

值得關注的重點公司

3M 醫療保健

概覽 3M Healthcare 製造、採購和銷售醫療、口腔護理和藥物輸送產品。該公司開發支持重症監護和慢性病預防和治療的產品和解決方案。感染預防解決方案是一個健康信息系統，可降低患者和醫護人員暴露於醫療相關感染的風險，並支持健康信息的彙編和利用。 3M Healthcare 作為 3M 的子公司運營，為製藥和生物技術公司提供吸入、透皮、微針、口服和局部給藥技術，以提高臨床和財務業績。

我們還為醫療設備製造商提供正畸解決方案、傷口護理解決方案、手術設備、消費者健康、微流體、醫用膠帶和粘合劑技術。

產品組合 PREVENA 療法 - 專為增強切口管理而設計，可在 SARS-CoV-2 爆發期間保護患者、外科醫生、工作人員、診所和醫院。

全球高級傷口護理市場報告提供對大約 45 多個市場數據表、40 多個數字和 180 頁的訪問。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
  • 驅動程序
    • 啟動與傷口護理相關的研究和投資活動
  • 約束因素
    • 與傷口護理產品相關的高成本
  • 機會
  • 影響分析

第5章產業要素

  • 波特的五種力量
  • 監管機構分析
  • 供應鏈分析
  • 報銷分析
  • PEST 分析
  • 定價分析

第 6 章按產品分類

  • 滲出液管理
    • 水凝膠
    • 泡沫
    • 矽膠敷料
      • 矽光敷料
      • 矽膠吸水敷料
      • 矽膠片
    • 水膠體
    • 海藻酸鹽
    • 超強吸水性
  • 傳染病對策
    • 銀傷口敷料
    • 膠原蛋白敷料
    • 非銀敷料
  • 皮膚替代品
    • 異種移植
    • 異體移植
    • 胎盤/羊水組織
    • 生物工程皮膚/人工替代品
  • 治療設備
    • 負壓傷口護理裝置（NPWT 裝置）
      • 傳統負壓傷口治療 (NPWT)
      • 泵
      • 罐
      • 梳妝台
      • 一次性使用負壓傷口治療 (NPWT)
    • 高壓氧治療儀
    • 超聲波噴霧/電刺激器
  • 加壓繃帶
    • 完全壓縮 - 2 層
    • 其他
  • 止血材料
  • 納米纖維敷料

第 7 章按傷口類型

  • 慢性傷口
    • 壓瘡（PU）
    • 下肢靜脈潰瘍 (VLU)
    • 糖尿病足潰瘍 (DFU)
  • 急性傷口

第 8 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 9 章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第 10 章公司簡介

  • 3M 醫療保健
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Urgo Medical
  • B. Braun Medical
  • Coloplast A/s
  • ConvaTec Inc
  • Derma Sciences, Inc
  • Paul Hartmann AG
  • Smith & Nephew
  • Medline Industries, Inc.
  • Acelity
  • Molnlycke Healthcare
  • Oranogenesis

第11章 全球高級傷口護理市場-DataM

簡介目錄
Product Code: DMHCIT586

Market Overview

The Advanced Wound Care Market size was valued US$ 10,318.90 million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.90% during the forecast period (2022-2029).

Advanced wound care comprises products that treat acute and chronic wounds, such as ulcers, burns, and post-operative wounds. The products, such as film and foam dressings, hydrogels, alginates, and hydrocolloids, keep the damage hydrated to encourage healing without occluding the wound. The market offers solutions to patients suffering from chronic wounds by providing them with readily reachable and priced products that can be used at their convenience. The advanced wound care management market report also covers various competing technologies, such as advanced wound dressing technologies, harmful pressure wound therapies (NPWT), biologics/bioactive products, and hyperbaric oxygen therapy devices.

Market Dynamics

The growth of the market is majorly driven by increasing aging population, advancements in technologies, raising prevalence of diabetics, increasing patient awareness, raising patient healthcare expenditure are the major factors driving the growth of the market

Rising research & investment activities related to wound care are expected to drive market growth

The presence of ongoing research activities is expected to boost the wound care market. For instance, in December 2018, according to new research from the McGill University Health Centre (MUHC) and McGill University showed the use of a new application, called Swift Skin and Wound, which measures accurately and charts the progression of skin wounds, could potentially have a significant impact on the clinical management and the patient outcomes. Clinicians and healthcare professionals are currently using the app at the McGill University Health Centre (MUHC) in Montreal.

Also, in March 2019, according to a study, published online recently in the journal Scientific Reports by a research team at the Ohio State University, stated that the electroceutical bandages could kill the bacteria around a wound, allowing the wounds to heal faster. ipLine Medical, Inc (Campbell, CA), completed a $12 million Series E round of financing to support the worldwide commercialization activities for the Zip Surgical Skin Closure product and the development of advanced tools for reducing costs in a bundled care environment. Financing was backed by a new investor, HighCape Partners (New York, NY), and existing investor MVM Life Science Partners LLP (Boston, MA). The company is an innovator in developing cost-effective, noninvasive surgical skin closure devices that improve surgical efficiency and patient satisfaction. Its leading surgical skin closure product is classified by the United States Food and Drug Administration as Class I, 510(k) Exempt.

The high cost associated with the wound care products is one of the major factors hindering the growth of the market

According to the National Health Service (NHS) in the United Kingdom, venous leg ulcers (VLUs), pressure ulcers (PUs) and DFUs are among the costliest wounds in UK. According to a UK-based study, the cost of these wound care was estimated at over £4.5 billion (5.72 USD billion), not accounting for the care of comorbidities or costs undertaken by patients themselves. No robust or cost-effective dressing is available except antimicrobial dressings (silver, iodine, or honey), which are preferred over nonmedicated dressings to heal chronic wounds.

Moreover, wound care products are prescribed in large quantities for use on an as-needed basis, which incurs additional cost. Advanced wound care products are expensive compared to traditional wound dressing techniques. Therefore, many patients opt for traditional dressings despite its slow healing process. This is posing a major challenge for the growth of the advanced wound dressings segment. The cost of treating chronic wounds in the U.S. is extremely high, with the charge per case ranging from $2,000 to $10,000 depending upon the condition and nursing costs. The cost of managing a pressure ulcer is estimated to be between $7,000 and $55,000 in the U.S., while the annual cost of all treatment is valued in billions.

COVID-19 Impact Analysis

The COVID-19 outbreak will impact the advanced wound care market in the initial phase of the forecast period. Due to nationwide lockdowns, denied wound care services and cancelled or postponed elective surgeries, the advanced wound care market is expected to register a certain decline during the forecast period. Many companies in the advanced wound care market are forced to halt their manufacturing and production operations, owing to spread of the virus. Moreover, business operations have been paused, owing to new government rulings, which directly influences revenue drift of the advanced wound care market. The hospital outpatient department (HOPD) wound clinics have been the primary site-of-care to treat these wounds but with the closing of several of these facilities during the initial COVID surge, many patients with chronic wounds were not seen, delayed treatment or began the transfer to the physician office for treatment. More than two-million non-emergency procedures were cancelled in the UK to free up healthcare resources to help fight against the pandemic. Similarly, the hospitals in the USA saw a 30-60% decline in hospital visits after the announcement of coronavirus as a pandemic. In fact, there is some evidence that wounds increased in severity since the start of the pandemic resulting in greater use of higher technology products and unfortunately, an increase in amputations.

Industry Analysis

The global advanced wound care market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, reimbursement analysis, supply chain analysis, pricing analysis, technological advancements etc.

Segment Analysis

Exudate management segment is expected to hold the largest market share in global advanced wound care market

Exudate is the fluid leaking from the wound, which has a vital role in the healing process. It is mainly water but also consists of nutrients, proteins, waste products and various types of cells such as platelets and macrophages. Exudate management is essential as it avoids significant pain, discomfort and suffering of the patient due to wounds; helps create an optimal environment for wound healing; and, prevents the risk of infection.

In chronic wounds, however, the exudate produced can be detrimental to the process. Wound exudate, particularly from chronic wounds, contains a cocktail of elements (cellular debris and enzymes), which can be highly corrosive, both to the wound bed and intact skin surrounding the wound. For the health professional caring for patients with chronic wounds, controlling exudate can be one of the biggest challenges. Managing wet wounds is costly in terms of dressing materials and nursing time and in the current economic climate within health care we are more than eve aware of reducing costs.

Geographical Analysis

North America region holds the largest market share in the global healthcare IT market

North America is dominating the global advanced wound care market in 2019 and estimated to hold significant market size over the forecast period (2020-2027) owing to the product innovations, rise in the incidence of diabetes cases, increasing healthcare spending and the growing aging population in this region. The increasing number of wound cases in the region are expected to boost the market. For instance, the National Institute of Health has estimated that 3% of the population of 65 years and above would have a wound at some time. An even higher rate of incidence is expected, owing to the traumatic injuries and ulcers endemic in resource-poor countries to other regions. Thus, the rising number of wounds is driving the market.

The ongoing research activities for wound management by the key players in the region is expected to boost the market. According to a study published on August 14, 2019, in the open-access journal PLOS ONE by Brennan Spiegel of Cedars-Sinai Health System and colleagues found that therapeutic virtual reality (VR) is emerging as an active, non-pharmacological treatment modality for pain, anxiety disorders, and distract patients during wound care. Thus, the presence of ongoing research activities is driving the market. The presence of key players developing wound care products in the region are expected to boost the market. For instance, on March 04, 2019 Organogenesis Holdings Inc. announced that PuraPly Antimicrobial (PuraPly AM) product has positively affected the course of healing in a variety of complex, chronic wounds that were previously unresponsive to treatment. Thus, the presence of key players launching different wound care products are driving the market.

Competitive Landscape

The advanced wound care market is highly competitive, owing to the presence of big brands. Also, the market is highly fragmented due to the presence of several large and regional players. The key players which are contributing to the growth of the global market include 3M Healthcare, Urgo Medical, B. Braun Medical, Coloplast A/s, ConvaTec Inc, Derma Sciences, Inc., Paul Hartmann AG, Smith & Nephew, Medline Industries, Inc., Acelity, Molnlycke Healthcare, Oranogenesis.

Key Companies to Watch

3M Health Care:

Overview: 3M Health Care Limited manufactures, procures, and markets medical, oral care, and drug delivery products. The company develops critical and chronic care products and solutions that help prevent and treat critical and chronic conditions across the continuum of care infection prevention solutions to reduce the risk of exposure to healthcare-associated infections for patients and healthcare professionals' health information systems to help compile and use health information. 3M Health Care Limited operates as a subsidiary of 3M Company for better clinical and financial performance inhalation, transdermal, micro needle, or oral and topical drug delivery technologies for pharmaceutical and biotechnology companies.

The company also offers orthodontic solutions, wound care solutions, surgical devices, consumer health, micro fluidics, medical grade tapes and adhesive technologies to medical device manufacturers.

Product Portfolio: PREVENA Therapy- It is uniquely engineered to empower incision management that works to protect patients, surgeons, staff, practices, and hospitals during the SARS-CoV-2 pandemic.

The global advanced wound care market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Rising research & investment activities related to wound care
  • 4.3. Restraints
    • 4.3.1. The high cost associated with the wound care products
  • 4.4. Opportunities
  • 4.5. Impact Analysis

5. Industry Factors

  • 5.1. Porter's Five Forces
  • 5.2. Regulator Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Reimbursement Analysis
  • 5.5. PEST Analysis
  • 5.6. Pricing Analysis

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 6.1.2. Market Attractiveness Index, By Product
  • 6.2. Exudate Management*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 6.2.3. Hydrogel
    • 6.2.4. Foam
    • 6.2.5. Silicone Dressing
      • 6.2.5.1. Silicone Lite Foam Dressing
      • 6.2.5.2. Silicone absorbent dressings
      • 6.2.5.3. Silicone gel sheets
    • 6.2.6. Hydrocolloids
    • 6.2.7. Alginate
    • 6.2.8. Super Absorbent
  • 6.3. Infection Management
    • 6.3.1. Silver Wound Dressing
    • 6.3.2. Collagen Dressing
    • 6.3.3. Non-Silver Dressing
  • 6.4. Skin Substitutes
    • 6.4.1. Xenograft
    • 6.4.2. Allograft
    • 6.4.3. Placenta/Amniotic Tissue
    • 6.4.4. Bioengineered skin/synthetic Substitutes
  • 6.5. Therapy Devices
    • 6.5.1. Negative Pressure Wound Therapies (NPWT Devices)
      • 6.5.1.1. Conventional Negative Pressure Wound Therapy (NPWT)
      • 6.5.1.1.1. Pumps
      • 6.5.1.1.2. Canisters
      • 6.5.1.1.3. Dressing Kits
      • 6.5.1.2. Single-Use Negative Pressure Wound Therapy (NPWT)
    • 6.5.2. Hyperbaric Oxygen Therapy
    • 6.5.3. Ultrasonic Mist and Electrical Stimulation Devices
  • 6.6. Compression Bandage
    • 6.6.1. Full Compression - 2 layers
    • 6.6.2. Others
  • 6.7. Hemostatic Dressing
  • 6.8. Nanofibre Dressing

7. By Wound Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
    • 7.1.2. Market Attractiveness Index, By Wound Type
  • 7.2. Chronic Wounds*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Pressure Ulcer (PU)
    • 7.2.4. Venous Leg Ulcer (VLU)
    • 7.2.5. Diabetic Foot Ulcer (DFU)
  • 7.3. Acute Wounds

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. The U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. South America
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Brazil
      • 8.3.5.2. Argentina
      • 8.3.5.3. Rest of South America
  • 8.4. Europe
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Germany
      • 8.4.5.2. The U.K.
      • 8.4.5.3. France
      • 8.4.5.4. Spain
      • 8.4.5.5. Italy
      • 8.4.5.6. Rest of Europe
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
      • 8.5.4.1. China
      • 8.5.4.2. India
      • 8.5.4.3. Japan
      • 8.5.4.4. Australia
      • 8.5.4.5. Rest of Asia-Pacific
  • 8.6. Middle East & Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. 3M Healthcare
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. Urgo Medical
  • 10.3. B. Braun Medical
  • 10.4. Coloplast A/s
  • 10.5. ConvaTec Inc
  • 10.6. Derma Sciences, Inc
  • 10.7. Paul Hartmann AG
  • 10.8. Smith & Nephew
  • 10.9. Medline Industries, Inc.
  • 10.10. Acelity
  • 10.11. Molnlycke Healthcare
  • 10.12. Oranogenesis

LIST NOT EXHAUSTIVE

11. Global Advanced Wound Care Market - DataM

  • 11.1. Appendix
  • 11.2. About Us
  • 11.3. Contact Us